Target intelligence / Profile preview

Ganglioside-induced differentiation-associated protein 1-like 1 (GDAP1L1)

Target
GDAP1L1
Molecular classification
Other, Glutathione S-transferase (GST) superfamily (C-terminal, N-terminal, thioredoxin-like domains)
01

Overview

Ganglioside-induced differentiation-associated protein 1-like 1 (GDAP1L1) is a protein-coding gene in humans, closely related in sequence and domain organization to GDAP1, which regulates mitochondrial dynamics, especially fission, and is associated with the glutathione S-transferase superfamily[1][2][5][6]. GDAP1L1 is predicted to localize to the mitochondrial outer membrane and is expressed in various tissues, but specific biological functions, involvement in disease, drug interactions, and safety profiles are not currently characterized in the literature or major genetic databases[1][5][6][7][9]. Unlike GDAP1, which is a validated regulator of mitochondrial structure whose mutations cause Charcot-Marie-Tooth neuropathy, GDAP1L1 has not been confirmed as a therapeutic target or a disease gene[2][6][8][9]. Current research describes GDAP1L1 as an uncharacterized or putative mitochondrial protein, with molecular features strongly matching those of the GST family and potential—but unproven—roles in neural cell function[1][2][3][4][5][7].

Other names
Ganglioside-induced differentiation-associated protein 1-like 1GDAP1L1GDAP1-L1dJ881L22.1dJ995J12.1.1
02

Biological functions

Unknown/Other (putative role in mitochondrial membrane structure and function by analogy to GDAP1)
03

Disease associations

Other (no confirmed direct association; GDAP1 mutations cause Charcot-Marie-Tooth disease, but not established for GDAP1L1)

Beyond the preview

Go deeper on Ganglioside-induced differentiation-associated protein 1-like 1 (GDAP1L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ganglioside-induced differentiation-associated protein 1-like 1 (GDAP1L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call